KKR & Co said on Friday it would buy chemical maker Chase in an all-cash deal valued at about $1.3 billion including debt, to help the private equity firm bolster its holdings in the chemical specialty sector.
Under the deal terms, KKR will buy all outstanding shares of Chase common stock for $127.50 apiece.
Chase manufactures chemicals such as adhesives and coating materials to be used in industries ranging from automotive and electronics to energy markets.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
Can’t stop reading? Read more
Harvard lab secures $39m private equity lifeline from İşbank arm to launch biotech venture
Harvard lab secures $39m private equity lifeline from İşbank arm to launch biotech venture İş...
Private credit boom lures ultra-wealthy as PE sentiment cools, says BlackRock
Private credit boom lures ultra-wealthy as PE sentiment cools, says BlackRock BlackRock reports...
US private equity-backed consortium led by Gareth Bale eyes Plymouth Argyle stake
US private equity-backed consortium led by Gareth Bale eyes Plymouth Argyle stake US private...